Efter 24 uger, var alle tilgængelige helbredelige isolater hos patienter som modtog nevirapin modstandsdygtige over denne agent, mens 18/ 21 (86%) patienter bar på sådanne isolater i 30- 60 uger.
At 24 weeks, all available isolates recoverable from patients receiving nevirapine were resistant to this agent, while 18/ 21 (86%) patients carried such isolates at 30-60 weeks.